Feng Ruizhi, Sang Qing, Kuang Yanping, Sun Xiaoxi, Yan Zheng, Zhang Shaozhen, Shi Juanzi, Tian Guoling, Luchniak Anna, Fukuda Yusuke, Li Bin, Yu Min, Chen Junling, Xu Yao, Guo Luo, Qu Ronggui, Wang Xueqian, Sun Zhaogui, Liu Miao, Shi Huijuan, Wang Hongyan, Feng Yi, Shao Ruijin, Chai Renjie, Li Qiaoli, Xing Qinghe, Zhang Rui, Nogales Eva, Jin Li, He Lin, Gupta Mohan L, Cowan Nicholas J, Wang Lei
From the State Key Laboratory of Genetic Engineering, Institutes of Biomedical Sciences, MOE Key Laboratory of Contemporary Anthropology, and Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan University (R.F., Q.S., Y.X., R.Q., X.W., H.W., Q.L., Q.X., L.J., L.H., L.W.), Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University (X.S., M.Y., J.C.), Department of Otolaryngology, Eye and ENT Hospital, Fudan University (L.G.), Department of Integrative Medicine and Neurobiology, State Key Laboratory of Medical Neurobiology, and Shanghai Medical College, Fudan University (Y.F.), the Reproductive Medicine Center, Shanghai Ninth Hospital, Shanghai Jiao Tong University (Y.K., Z.Y., S.Z., B.L.), Shanghai Institute of Planned Parenthood Research (Z.S., M.L., H.S.), and Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University (L.H.), Shanghai, Reproductive Medicine Center, Shaanxi Maternal and Child Care Service Center, Shaanxi (J.S.), and Key Laboratory for Developmental Genes and Human Disease, Ministry of Education, Institute of Life Sciences, Southeast University, Nanjing (R.C.) - all in China; the Department of Biochemistry and Molecular Pharmacology, New York University Langone Medical Center, New York (G.T., N.J.C.); the Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago (A.L., Y. Fukuda, M.L.G.); the Department of Physiology-Endocrinology, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden (R.S.); the Department of Genetics, Development and Cell Biology, Iowa State University, Ames (M.L.G.); and the Life Sciences Division, Lawrence Berkeley National Laboratory (R.Z., E.N.), the Molecular and Cell Biology Department (E.N.), and the Howard Hughes Medical Institute (E.N.), University of California Berkeley, Berkeley.
N Engl J Med. 2016 Jan 21;374(3):223-32. doi: 10.1056/NEJMoa1510791.
Background Human reproduction depends on the fusion of a mature oocyte with a sperm cell to form a fertilized egg. The genetic events that lead to the arrest of human oocyte maturation are unknown. Methods We sequenced the exomes of five members of a four-generation family, three of whom had infertility due to oocyte meiosis I arrest. We performed Sanger sequencing of a candidate gene, TUBB8, in DNA samples from these members, additional family members, and members of 23 other affected families. The expression of TUBB8 and all other β-tubulin isotypes was assessed in human oocytes, early embryos, sperm cells, and several somatic tissues by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay. We evaluated the effect of the TUBB8 mutations on the assembly of the heterodimer consisting of one α-tubulin polypeptide and one β-tubulin polypeptide (α/β-tubulin heterodimer) in vitro, on microtubule architecture in HeLa cells, on microtubule dynamics in yeast cells, and on spindle assembly in mouse and human oocytes. Results We identified seven mutations in the primate-specific gene TUBB8 that were responsible for oocyte meiosis I arrest in 7 of the 24 families. TUBB8 expression is unique to oocytes and the early embryo, in which this gene accounts for almost all the expressed β-tubulin. The mutations affect chaperone-dependent folding and assembly of the α/β-tubulin heterodimer, disrupt microtubule behavior on expression in cultured cells, alter microtubule dynamics in vivo, and cause catastrophic spindle-assembly defects and maturation arrest on expression in mouse and human oocytes. Conclusions TUBB8 mutations have dominant-negative effects that disrupt microtubule behavior and oocyte meiotic spindle assembly and maturation, causing female infertility. (Funded by the National Basic Research Program of China and others.).
背景 人类生殖依赖于成熟卵母细胞与精子细胞融合形成受精卵。导致人类卵母细胞成熟停滞的遗传事件尚不清楚。方法 我们对一个四代家族的五名成员进行了外显子组测序,其中三名成员因卵母细胞减数分裂I停滞而不育。我们对这些成员、其他家族成员以及另外23个受影响家族的成员的DNA样本中的候选基因TUBB8进行了桑格测序。通过定量逆转录-聚合酶链反应分析评估了TUBB8和所有其他β-微管蛋白亚型在人类卵母细胞、早期胚胎、精子细胞和几种体细胞组织中的表达。我们在体外评估了TUBB8突变对由一个α-微管蛋白多肽和一个β-微管蛋白多肽组成的异二聚体(α/β-微管蛋白异二聚体)组装的影响,对HeLa细胞中微管结构的影响,对酵母细胞中微管动力学的影响,以及对小鼠和人类卵母细胞中纺锤体组装的影响。结果 我们在灵长类特异性基因TUBB8中鉴定出七个突变,这些突变导致了24个家族中的7个家族出现卵母细胞减数分裂I停滞。TUBB8表达在卵母细胞和早期胚胎中是独特的,在这些细胞中该基因几乎占所有表达的β-微管蛋白。这些突变影响α/β-微管蛋白异二聚体的伴侣依赖性折叠和组装,破坏培养细胞中表达时的微管行为,改变体内微管动力学,并在小鼠和人类卵母细胞中表达时导致灾难性的纺锤体组装缺陷和成熟停滞。结论 TUBB8突变具有显性负效应,破坏微管行为、卵母细胞减数分裂纺锤体组装和成熟,导致女性不育。(由中国国家基础研究计划等资助。)